- Home
- MNRO vs EBS Comparison
MNRO vs EBS Comparison
Compare MNRO & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNRO | EBS |
|---|---|---|
| Founded | 1957 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Automotive Aftermarket | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 472.5M | 423.6M |
| IPO Year | 1994 | 2006 |
Fundamental Metrics
Financial Performance| Metric | MNRO | EBS |
|---|---|---|
| Price | $15.71 | $8.43 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $16.00 | $12.00 |
| AVG Volume (30 Days) | ★ 1.5M | 924.6K |
| Earning Date | 05-27-2026 | 04-30-2026 |
| Dividend Yield | ★ 6.69% | N/A |
| EPS Growth | 113.64 | ★ 125.83 |
| EPS | 0.03 | ★ 0.07 |
| Revenue | ★ $1,157,176,000.00 | $742,900,000.00 |
| Revenue This Year | N/A | $1.29 |
| Revenue Next Year | $1.59 | N/A |
| P/E Ratio | $514.00 | ★ $114.43 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.51 | $5.62 |
| 52 Week High | $23.91 | $14.06 |
Technical Indicators
Market Signals| Indicator | MNRO | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 47.81 | 51.45 |
| Support Level | $14.90 | $7.77 |
| Resistance Level | $18.56 | $8.54 |
| Average True Range (ATR) | 0.83 | 0.43 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 57.56 | 80.61 |
Price Performance
Historical ComparisonAbout MNRO Monro Inc.
Monro Inc is an operator of retail tire and automotive repair stores in the United States. The company offers replacement tires and tire related services, automotive undercar repair services, and a broad range of routine maintenance services, on passenger cars, light trucks, and vans. It also provides other products and services for brakes; mufflers and exhaust systems; and steering, drive train, suspension, and wheel alignment.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.